Pilocarpine is an M3 muscarinic agonist that is widely used for the treatment of xerostomia caused by various diseases and medical conditions. Pilocarpine induced the secretion of salivary fluid in perfused submandibular glands of rats. The secretion of salivary fluid observed after removal of pilocarpine was referred to as residual fluid secretion. The volume of fluid and time of the residual secretion depended on the dose of pilocarpine. Such a residual effect of pilocarpine was observed on fluid secretion via the paracellular pathway and oxygen consumption. When a muscarinic antagonist was added to the perfusate immediately after cessation of pilocarpine, residual secretion of salivary fluid did not occur. These observations indicate tha...
Peripheral treatment with cholinergic or adrenergic agonists results in salivation and the possibili...
We determined the effects of moxonidine and rilmenidine 20 mol (alpha(2)-adrenergic and imidazoline ...
Anti-hypertensive drugs that act oil central alpha(2)-adrenoceptors and imidazoline receptors usuall...
Xerostomia is the symptom of dry mouth often seen in patients who receive head and neck radiation th...
Although cholinergic agonists such as pilocarpine injected peripherally can act directly on salivary...
Pilocarpine has been used as a choice of drugs for treatment of impaired salivary flow. Although con...
In the present study we investigated the effects of electrolytic lesions of the lateral hypothalamus...
Background and purpose: Recent evidence has suggested that pilocarpine (ACh receptor agonist) inject...
Peripheral injection of pilocarpine, a cholinergic muscarinic agonist, induces salivation, water int...
The effect in rats of an anteroventral third ventricle (AV3V) electrolytic lesion on salivary secret...
Previous reports suggested that there is no significant difference in the binding affinity of piloca...
Our studies have focused on the effect of L-NG-nitroarginine methyl ester (L-NAME), an inhibitor of ...
Peripheral treatment with the cholinergic agonist pilocarpine induces intense salivation that is inh...
Our studies have focused on the effect of injection of L-NAME and sodium nitroprussiate (SNP) on the...
Central cholinergic activation by pilocarpine induces salivation dependent on the integrity of foreb...
Peripheral treatment with cholinergic or adrenergic agonists results in salivation and the possibili...
We determined the effects of moxonidine and rilmenidine 20 mol (alpha(2)-adrenergic and imidazoline ...
Anti-hypertensive drugs that act oil central alpha(2)-adrenoceptors and imidazoline receptors usuall...
Xerostomia is the symptom of dry mouth often seen in patients who receive head and neck radiation th...
Although cholinergic agonists such as pilocarpine injected peripherally can act directly on salivary...
Pilocarpine has been used as a choice of drugs for treatment of impaired salivary flow. Although con...
In the present study we investigated the effects of electrolytic lesions of the lateral hypothalamus...
Background and purpose: Recent evidence has suggested that pilocarpine (ACh receptor agonist) inject...
Peripheral injection of pilocarpine, a cholinergic muscarinic agonist, induces salivation, water int...
The effect in rats of an anteroventral third ventricle (AV3V) electrolytic lesion on salivary secret...
Previous reports suggested that there is no significant difference in the binding affinity of piloca...
Our studies have focused on the effect of L-NG-nitroarginine methyl ester (L-NAME), an inhibitor of ...
Peripheral treatment with the cholinergic agonist pilocarpine induces intense salivation that is inh...
Our studies have focused on the effect of injection of L-NAME and sodium nitroprussiate (SNP) on the...
Central cholinergic activation by pilocarpine induces salivation dependent on the integrity of foreb...
Peripheral treatment with cholinergic or adrenergic agonists results in salivation and the possibili...
We determined the effects of moxonidine and rilmenidine 20 mol (alpha(2)-adrenergic and imidazoline ...
Anti-hypertensive drugs that act oil central alpha(2)-adrenoceptors and imidazoline receptors usuall...